Several new, non-benzodiazepine hypnotic drugs have recently been mark
eted (zopiclone, zolpidem) or are in development (zaleplon, SX 3228).
These compounds act at benzodiazepine (BZ) (omega) receptors but have
mechanisms of action which are not identical to those of benzodiazepin
es; in particular, zolpidem, zaleplon and SX 3228 have been reported t
o have selectivity for the BZ(1) (omega(1)) receptor subtype. In the p
resent study the effects of the four hypnotic drugs were investigated
in rats trained to discriminate ethanol (1 g/kg). Comparisons were mad
e with pentobarbital and the benzodiazepines, lorazepam and midazolam.
The two benzodiazepines and the barbiturate produced dose-related sub
stitution for ethanol. In contrast, zolpidem, zaleplon, SX 3228 and zo
piclone gave rise to only partial (maximum effect 50-67%) substitution
, even at doses which greatly reduced rates of lever pressing. The lim
ited ethanol-like effects of zolpidem, zaleplon and SX 3228 may be rel
ated to the more selective mechanism of action of these compounds. It
is not clear why the effects of zopiclone differed from those of the b
enzodiazepines.